Angiographic and clinical comparison of novel Orsiro Hybrid sirolimus-eluting stents and Resolute Integrity zotarolimus-eluting stents in all-comers with coronary artery disease (ORIENT trial): study protocol for a randomized controlled trial

Clinical and angiographic experience with a third-generation drug-eluting Orsiro stent in the treatment of single de novo coronary artery lesions (BIOFLOW-I): a prospective, first-in-man study

(2013) Martial Hamon et al.   EuroIntervention

Stent Thrombosis With Everolimus-Eluting Stents

(2012) Tullio Palmerini et al.   Circulation-Cardiovascular Interventions

Third Universal Definition of Myocardial Infarction

(2012) Kristian Thygesen et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Second- and third-generation drug-eluting coronary stents

(2011) I. Akin et al.   HERZ

The Impact of Patient and Lesion Complexity on Clinical and Angiographic Outcomes After Revascularization With Zotarolimus- and Everolimus-Eluting Stents

(2011) Giulio G. Stefanini et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Clinical Evaluation of the Resolute Zotarolimus-Eluting Coronary Stent System in the Treatment of De Novo Lesions in Native Coronary Arteries

(2011) Alan C. Yeung et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial

(2011) Giulio G Stefanini et al.   LANCET

Second-Generation Drug-Eluting Coronary Stents

(2010) Richard A. Lange et al.   NEW ENGLAND JOURNAL OF MEDICINE

Percutaneous coronary interventions for non-acute coronary artery disease: a quantitative 20-year synopsis and a network meta-analysis

(2009) Thomas A Trikalinos et al.   LANCET

Comparison of an Everolimus-Eluting Stent and a Paclitaxel-Eluting Stent in Patients With Coronary Artery Disease

(2008) Gregg W. Stone   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION